DWP450 Treatment in Subjects With Benign Masseteric Hypertrophy

Summary

This study is A Randomized, Double-blind, Placebo-controlled, Phase II Optimal Dose-finding Study to Determine the Safety and Efficacy of DWP450 in Subjects with Benign Masseteric Hypertrophy

Timeline

Start

2017-12

Primary completion

2018-10

Completion

2018-10

Drugs

Indications